Literature DB >> 27339678

Hematological Issues in Liver Disease.

Michael G Allison1, Carl B Shanholtz2, Ashutosh Sachdeva3.   

Abstract

Acute and chronic liver failure are associated with numerous alterations in different features of the coagulation system. Consequently, there is widespread confusion regarding the potential for both bleeding and thrombosis in patients with liver disease. The risk of bleeding is related to the hemodynamic changes in portal pressures and venous congestion whereas the thrombotic risk stems from changes in the coagulation system. Antithrombotic prophylaxis and treatment of patients with hemorrhage and thrombosis requires careful assessment, interpretation of laboratory workup, and attention to coexistent morbidities. A framework for the management of these conditions is presented for clinicians.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute liver failure; Anticoagulation; Cirrhosis; Coagulopathy; Thrombocytopenia; Thrombosis

Mesh:

Substances:

Year:  2016        PMID: 27339678     DOI: 10.1016/j.ccc.2016.03.004

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  4 in total

Review 1.  Acute Fatty Liver of Pregnancy: Pathophysiology, Anesthetic Implications, and Obstetrical Management.

Authors:  Emily E Naoum; Lisa R Leffert; Hovig V Chitilian; Kathryn J Gray; Brian T Bateman
Journal:  Anesthesiology       Date:  2019-03       Impact factor: 7.892

2.  Predicting packed red blood cell transfusion in living donor liver transplantation: A retrospective analysis.

Authors:  Shweta A Singh; Kelika Prakash; Sandeep Sharma; An Anil; Viniyendra Pamecha; Guresh Kumar; Ajeet Bhadoria
Journal:  Indian J Anaesth       Date:  2019-02

3.  Increasing plasma ADAMTS13 activity is associated with HBeAg seroconversion in chronic hepatitis B patients during 5 years of entecavir treatment.

Authors:  Renyong Guo; Yirui Xie; Jiezuan Yang; Haifeng Lu; Ping Ye; Linfeng Jin; Wenqin Lin
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

4.  Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis.

Authors:  Wenhua Ren; Jing Zhang; Yuying Chen; Meng Wen; Yu Su; Yujing Zhao; Shan Lu; Jun Wu
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.